Keji Xie

机构：Guangzhou First People's Hospital, Guangzhou Medical University

发表论文 80 篇 · 总被引 973 次 · h-index 15

代表论文

• Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial (2024 · Journal of Clinical Oncology · 被引 158)
• Tumor‐derived exosomal BCYRN1 activates WNT5A/VEGF‐C/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancer (2021 · Clinical and Translational Medicine · 被引 103)
• Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer (2021 · Journal of Experimental & Clinical Cancer Research · 被引 97)
• A phase 3, double-blind, randomized placebo-controlled efficacy and safety study of abiraterone acetate in chemotherapy-naïve patients with mCRPC in China, Malaysia, Thailand and Russia (2017 · Asian journal of urology · 被引 31)
• A single-blind randomized control trial of trigonal versus nontrigonal Botulinum toxin-A injections for patients with urinary incontinence and poor bladder compliance secondary to spinal cord injury (2020 · Journal of Spinal Cord Medicine · 被引 17)
• Self-Care and Quality of Life in Elderly Chinese Patients with Benign Prostatic Hyperplasia (2019 · Nursing Science Quarterly · 被引 12)